You Lu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC (NCT05092412) | You Lu | 2022-03-02 |
Track You Lu automatically
Every clearance here is in the API, with alerts when new ones post.